We rank companies based on fund manager, research analyst and news sentiment
ACST stock icon

Acasti Pharma, Inc.
ACST

$3.4
0.15%
 

About: Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.

Employees: 32

0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

14% more capital invested

Capital invested by funds: $1.44M [Q3] → $1.65M (+$209K) [Q4]

0.88% less ownership

Funds ownership: 6.96% [Q3] → 6.08% (-0.88%) [Q4]

30% less funds holding

Funds holding: 10 [Q3] → 7 (-3) [Q4]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$6
76%
upside
Avg. target
$6
76%
upside
High target
$6
76%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Craig-Hallum
Chase Knickerbocker
76%upside
$6
Buy
Initiated
7 Feb 2024

Financial journalist opinion